Incyte Corporation

Healthcare · Biotechnology

115.30$ -1.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Incyte Corporation (INCY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 7,873 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INCY
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	1,544	1,639	1,607	1,639	2,374	2,303	2,306	2,397	2,520	2,646	2,754	2,948	3,215	3,427	2,752	3,212	3,307	3,561	3,661	3,905	4,199	4,933	5,054	5,319	5,510	5,841	5,798	6,208	6,388	6,782	7,136	4,662	5,012	5,444	5,749	5,821	6,330	6,958	7,339	7,873
Current Assets	887	994	819	845	1,541	1,505	1,470	1,598	1,700	1,856	1,930	2,059	2,365	2,537	1,716	2,078	2,159	2,360	2,450	2,620	2,924	3,119	3,288	3,626	3,821	4,093	3,972	4,264	4,403	4,645	4,849	2,567	2,809	3,239	3,507	3,644	4,278	5,024	5,484	6,119
Cash	580	652	362	452	1,128	900	894	929	1,112	1,164	1,300	1,416	1,702	1,833	1,043	1,327	1,498	1,513	1,670	1,798	1,999	2,057	2,257	2,435	2,691	2,951	2,821	3,131	3,227	3,213	3,346	987	1,304	1,688	1,942	1,955	2,455	3,098	3,461	3,982
Cash & Short-Term Investments	717	809	512	609	1,281	1,170	1,171	1,198	1,375	1,438	1,581	1,696	1,986	2,118	1,303	1,589	1,735	1,801	1,962	2,081	2,284	2,348	2,544	2,722	2,977	3,239	3,113	3,423	3,516	3,656	3,851	1,519	1,775	2,158	2,409	2,422	2,930	3,581	4,016	4,536
Receivables	132	149	245	170	198	266	220	316	248	308	244	303	276	309	352	420	356	482	397	438	517	616	562	683	618	645	624	638	657	744	746	739	758	853	823	843	896	1,024	1,051	1,125
Inventory	4.1	4.1	4.0	2.9	3.3	6.5	4.6	5.9	6.0	10	11	6.5	13	17	14	16	17	16	17	17	21	28	35	55	46	42	41	36	57	63	64	101	70	59	64	83	83	101	116	113
Property, Plant & Equipment	152	168	193	219	247	260	265	268	301	320	338	339	347	378	410	454	498	560	595	689	714	724	729	721	742	739	742	749	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	156	133	133	133
Intangible Assets	276	270	265	260	242	237	232	226	221	215	210	205	199	194	188	183	178	172	167	162	156	151	145	140	135	129	141	135	129	124	118	114	120	114	108	126	119	117	110	103
Total Liabilities	1,174	1,219	641	613	617	672	678	664	717	720	669	700	792	828	815	868	917	950	934	969	1,050	1,163	1,191	1,234	1,284	1,471	1,335	1,468	1,457	1,592	1,741	1,665	1,841	1,997	2,082	1,650	1,679	1,803	1,787	1,528
Current Liabilities	241	1,219	305	293	320	375	381	368	422	415	364	367	492	500	503	557	606	631	624	660	743	854	886	927	1,007	1,157	1,006	1,119	1,125	1,240	1,396	1,337	1,502	1,642	1,720	1,279	1,339	1,515	1,490	1,312
Short-Term Debt	162	651	42	23	24	7.4	7.5	7.6	7.6	19	10	0.8	11	28	28	30	25	15	14	13	12	13	13	12	12	11	11	10	9.2	9.1	8.5	8.8	8.3	10	10	11	10	10	4.4	9.8
Accounts Payable	58	76	86	69	70	68	74	76	95	104	70	66	95	84	61	91	123	99	85	122	115	172	153	195	163	278	56	156	139	110	164	148	179	197	196	241	172	210	229	250
Long-Term Debt	643	651	42	23	24	17	17	17	17	17	18	18	18	18	19	–	–	–	–	–	–	–	–	–	–	–	–	–	–	29	29	29	28	34	–	–	–	–	–	–
Shareholders' Equity	370	419	966	1,027	1,758	1,631	1,628	1,733	1,803	1,926	2,086	2,247	2,423	2,598	1,938	2,345	2,391	2,611	2,728	2,936	3,149	3,770	3,863	4,085	4,227	4,370	4,463	4,741	4,931	5,190	5,394	2,997	3,171	3,448	3,668	4,171	4,651	5,167	5,552	6,344
Retained Earnings	-1,684	-1,675	-1,864	-1,876	-1,840	-1,990	-2,028	-1,976	-1,947	-1,878	-1,775	-1,670	-1,542	-1,431	-2,151	-1,861	-1,876	-1,726	-1,673	-1,523	-1,342	-778	-740	-578	-466	-437	-416	-212	-41	160	330	-1,380	-1,274	-1,073	-915	-510	-86	214	517	1,103
Shares Outstanding	194	195	195	205	213	211	212	215	216	216	217	217	218	219	217	220	219	221	222	222	222	222	223	224	224	225	226	226	226	226	227	218	196	197	198	199	201	205	207	208

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings